David Gwynne

Dr. Gwynne has worked in the biopharmaceutical industry since 1984 holding positions in both R&D and in business development. Dr. Gwynne has led R&D teams at Allelix Biopharmaceuticals and at Cambridge NeuroScience. In addition, Dr. Gwynne has held senior business development positions at Cambridge NeuroScience, CeNeS, Cita Pharmaceuticals and, most recently, as VP Business Development at Indevus Pharmaceuticals, where he completed four corporate licensing deals. Dr. Gwynne has experience in several therapeutic areas with emphasis on CNS disorders and urology. Dr. Gwynne received his Ph.D. from McGill University.